1. Parikh, Anuraag, Shin, JuneHo, Faquin, William, Sunwoo, John B, Puram, Sidharth V. . Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma. In Journal for immunotherapy of cancer, 8, . doi:10.1136/jitc-2020-001048. https://pubmed.ncbi.nlm.nih.gov/32958684/
2. Chang, Tsung-Ming, Chiang, Yao-Chang, Lee, Chiang-Wen, Liu, Ju-Fang, Kou, Yu Ru. 2023. CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway. In International journal of biological sciences, 19, 1455-1470. doi:10.7150/ijbs.79438. https://pubmed.ncbi.nlm.nih.gov/37056937/
3. Li, Nan, Liu, Hong, Xue, Yujia, Fan, Zhiwen, Xu, Yong. 2023. Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking. In EMBO molecular medicine, 15, e16592. doi:10.15252/emmm.202216592. https://pubmed.ncbi.nlm.nih.gov/36722664/
4. Wang, Yanjing, Wang, Siyi, Niu, Yuchen, Ma, Buyong, Li, Jingjing. 2023. Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation. In International journal of molecular sciences, 24, . doi:10.3390/ijms242216027. https://pubmed.ncbi.nlm.nih.gov/38003215/
5. Sturmlechner, Ines, Zhang, Cheng, Sine, Chance C, Li, Hu, van Deursen, Jan M. 2021. p21 produces a bioactive secretome that places stressed cells under immunosurveillance. In Science (New York, N.Y.), 374, eabb3420. doi:10.1126/science.abb3420. https://pubmed.ncbi.nlm.nih.gov/34709885/
6. Gowhari Shabgah, Arezoo, Haleem Al-Qaim, Zahraa, Markov, Alexander, Mohammad Gheibihayat, Seyed, Gholizadeh Navashenaq, Jamshid. 2021. Chemokine CXCL14; a double-edged sword in cancer development. In International immunopharmacology, 97, 107681. doi:10.1016/j.intimp.2021.107681. https://pubmed.ncbi.nlm.nih.gov/33932697/